Enhanced Intramucosal Cytotoxic Lymphocyte Gene Expression in Ulcerative Colitis

&NA; The histopathology of the mucosal lesions in ulcerative colitis suggests that cellular immune hyperactivity plays a role in the pathogenesis of ulcerative colitis. The role of colonic mucosal cytotoxic lymphocytes in ulcerative colitis is highly controversial. In vitro determinations of cytotoxic lymphocyte function vary according to the experimental conditions and target cells employed. Transcription of the cytotoxic molecules granzyme B and perforin are specific for activated cytotoxic lymphocytes. We investigated whether activated cytotoxic lymphocytes are present in ulcerative colitis lesions via identification of granzyme B, perforin, and interleukin 2 transcripts. RNA was extracted from endoscopic colonic biopsies taken from normal and ulcerative colitis patients. An aliquot was reverse transcribed, followed by gene amplification in the polymerase chain reaction. A competitive template was incorporated within the reaction permitting the quantitation of specific mRNA species. Granzyme B and perforin levels of reverse transcribed cDNAs (RT‐cDNAs) were significantly elevated in active ulcerative colitis as compared to normal colonic tissues (p = 0.0081 and p = 0.0018, respectively) when calculated as a ratio with the RT‐cDNA of the constitutively expressed gene GAPDH. Interleukin 2 mRNA measurements did not vary between normal and UC samples to a statistically significant degree. These data suggest heightened lymphocyte cytotoxic function within ulcerative colitis mucosal lesions.

[1]  C. Elson,et al.  Immunology of inflammatory bowel disease , 1996 .

[2]  J. Tschopp,et al.  A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Lipman,et al.  Heightened intragraft CTL gene expression in acutely rejecting renal allografts. , 1994, Journal of immunology.

[4]  Timothy J. Ley,et al.  Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells , 1994, Cell.

[5]  R. Zinkernagel,et al.  Immune responses in interleukin-2-deficient mice. , 1993, Science.

[6]  A. Feller,et al.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.

[7]  A. Cesano,et al.  Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. , 1993, Journal of immunology.

[8]  C. Fiocchi,et al.  Immune activation genes in inflammatory bowel disease. , 1993, Gastroenterology.

[9]  G. Heinze,et al.  Anti-CD2 and anti-CD3 induced T cell cytotoxicity of human intraepithelial and lamina propria lymphocytes. , 1992, Gut.

[10]  R. Aebersold,et al.  Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions , 1992, The Journal of experimental medicine.

[11]  E. Podack,et al.  Perforin expression in human peripheral blood mononuclear cells. Definition of an IL-2-independent pathway of perforin induction in CD8+ T cells. , 1992, Journal of immunology.

[12]  T. Bayless,et al.  Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. , 1992, Gastroenterology.

[13]  H. Blöcker,et al.  Analysis of cytokine mRNA levels in interleukin‐4‐transgenic mice by quantitative polymerase chain reaction , 1992, European journal of immunology.

[14]  C. Helgason,et al.  Quantitative polymerase chain reaction analysis of cytotoxic cell proteinase gene transcripts in T cells. Pattern of expression is dependent on the nature of the stimulus. , 1992, The Journal of biological chemistry.

[15]  M. Álvarez-Mon,et al.  Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2. , 1992, Gut.

[16]  J. Brynskov,et al.  Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. , 1992, Gut.

[17]  C. Fiocchi,et al.  Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease. , 1991, Gastroenterology.

[18]  M. Suthanthiran,et al.  Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction , 1991, The Journal of experimental medicine.

[19]  R. Macdermott,et al.  Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. , 1991, Gastroenterology.

[20]  P. Vassalli,et al.  Cytotoxic differentiation of mouse gut thymodependent and independent intraepithelial T lymphocytes is induced locally. Correlation between functional assays, presence of perforin and granzyme transcripts, and cytoplasmic granules , 1991, The Journal of experimental medicine.

[21]  J. Slot,et al.  Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes , 1991, The Journal of experimental medicine.

[22]  R. D. Hanson,et al.  Structure and expression of a cluster of human hematopoietic serine protease genes found on chromosome 14q11.2. , 1991, The Journal of biological chemistry.

[23]  R. D. Hanson,et al.  Transcriptional activation of the human cytotoxic serine protease gene CSP-B in T lymphocytes , 1990, Molecular and cellular biology.

[24]  C. Frégeau,et al.  Cloning of a gene that encodes a new member of the human cytotoxic cell protease family. , 1990, Biochemistry.

[25]  S. Perrin,et al.  Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Rafii,et al.  Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A , 1989, The Journal of experimental medicine.

[27]  C. Fiocchi,et al.  Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls. , 1989, Gastroenterology.

[28]  A. Lanzavecchia,et al.  Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes. , 1988, Journal of immunology.

[29]  P. Gibson,et al.  Lysis of colonic epithelial cells by allogeneic mononuclear and lymphokine activated killer cells derived from peripheral blood and intestinal mucosa: evidence against a pathogenic role in inflammatory bowel disease. , 1988, Gut.

[30]  J. Tschopp,et al.  Granzymes, a Family of Serine Proteases Released from Granules of Cytolytic T Lymphocytes upon T Cell Receptor Stimulation , 1988, Immunological reviews.

[31]  Kendall A. Smith,et al.  CHAPTER 1 – INTERLEUKIN 2: A 10-YEAR PERSPECTIVE , 1988 .

[32]  J. D. Young,et al.  Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Tschopp,et al.  Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes. , 1985, The Journal of biological chemistry.

[34]  R. Tubbs,et al.  Human intestinal mucosal mononuclear cells exhibit lymphokine-activated killer cell activity. , 1985, Gastroenterology.

[35]  E. Podack,et al.  Cytolytic T cell granules. Isolation, structural, biochemical, and functional characterization , 1984, The Journal of experimental medicine.

[36]  Craig W. Reynolds,et al.  Cytolytic activity of purified cytoplasmic granules from cytotoxic rat large granular lymphocyte tumors , 1984, The Journal of experimental medicine.

[37]  J. Finke,et al.  Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. , 1984, Gastroenterology.

[38]  H. Eisen,et al.  The site of action of N-alpha-tosyl-L-lysyl-chloromethyl-ketone (TLCK) on cloned cytotoxic T lymphocytes. , 1983, Journal of immunology.

[39]  H. L. MacKechnie.  The immunology of inflammatory bowel disease. , 1982, Henry Ford Hospital medical journal.

[40]  W. Bartnik,et al.  Human colonic intraepithelial and lamina proprial lymphocytes: cytotoxicity in vitro and the potential effects of the isolation method on their functional properties. , 1981, Gut.

[41]  R. Macdermott,et al.  Human intestinal mononuclear cells. II. Demonstration of a naturally occurring subclass of T cells which respond in the allogeneic mixed leukocyte reaction but do not effect cell-mediated lympholysis. , 1981, Gastroenterology.

[42]  R. Macdermott,et al.  Human intestinal mononuclear cells: I. Investigation of antibody-dependent, lectin-induced, and spontaneous cell-mediated cytotoxic capabilities , 1980 .

[43]  R. Macdermott,et al.  Human intestinal mononuclear cells. I. Investigation of antibody-dependent, lectin-induced, and spontaneous cell-mediated cytotoxic capabilities. , 1980, Gastroenterology.

[44]  A. Pardee,et al.  Changes in the synthesis of actin and other cell proteins after stimulation of serum-arrested cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Bookman,et al.  Characteristics of isolated intestinal mucosal lymphoid cells in inflammatory bowel disease. , 1979, Gastroenterology.

[46]  C. Byus,et al.  Ribonucleic acid isolated by cesium chloride centrifugation. , 1974, Biochemistry.

[47]  R. G. Shorter,et al.  Further studies on in vitro cytotoxicity of lymphocytes from patients with ulcerative and granulomatous colitis for allogeneic colonic epithelial cells, including the effects of colectomy. , 1969, Gastroenterology.

[48]  P. Perlmann,et al.  In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on human fetal colon cells. , 1963 .

[49]  P. Perlmann,et al.  IN VITRO STUDIES OF ULCERATIVE COLITIS : I. REACTIONS OF PATIENTS' SERUM WITH HUMAN FETAL COLON CELLS IN TISSUE CULTURES , 1963 .

[50]  Maxwell Wilson.  FINAL REPORT ON A THERAPEUTIC TRIAL , 1955 .

[51]  S. Truelove,et al.  Cortisone in ulcerative colitis; final report on a therapeutic trial. , 1955, British medical journal.

[52]  S. Truelove,et al.  Cortisone in Ulcerative Colitis , 1954 .